Sino-Dental® Observation | BONANGA Launches Bonabone® Collagen Bone Filling Material for Oral Use, with Over 12 Million Cumulative Global Cases Across the Full Product Series

DentalGoodNews | On June 9, 2026, BONANGA was interviewed by DENTALGOODNEWS (Leading Dental Industry Media, DGN) during the 30th Sino-Dental (China International Dental Equipment, Materials & Technology Exhibition). The company introduced multiple products in the fields of oral soft tissue regeneration, hard tissue regeneration, and wound management, with a focus on showcasing the debut of its new oral bone filling material, Bonabone® collagen.

It is reported that Bonabone® collagen is prepared using a co-blending, co-polymerization, and freeze-drying technology, resulting in a block-shaped product. Before use, it is infiltrated, and after infiltration, it maintains a stable shape without disintegrating when exposed to blood or saline. This feature addresses a clinical pain point of traditional granular Bone Graft Substitute (BGS): poor-quality granular BGS tends to loosen and drift when encountering blood during bone grafting, affecting surgical procedures and osteogenesis outcomes. According to the brand, Bonabone® collagen is positioned as a domestic alternative for implant bone grafting surgeries, offering ease of use and strong price competitiveness.

Beyond Bonabone® collagen, the other two hard tissue regeneration materials also demonstrate competitiveness and differentiated advantages. Bonabone® oral bone filling material is sourced from controlled natural bovine cancellous bone, processed through exclusive low-temperature (temperature-controlled) segmented calcination and special degreasing and deproteinization techniques. Bonabone® membrane is derived from natural porcine pericardial collagen, providing a degradation rate consistent with the bone formation cycle (3-6 months), with a porosity of 80% and good tear resistance in a hydrated state.

In terms of overall quality control, the company has obtained the production quality management system certification issued by BSI and passed the second audit with zero non-conformance records. Its products meet the stringent market access requirements of countries worldwide. To date, BONANGA's full product line has been used in over 12 million cases globally, with expectations to exceed 13 million cases within the year.

About BONANGA Technology (Beijing) Co., Ltd. (BONANGA): It is a Beijing "Specialized, Fined, Peculiar, and Innovative" small and medium-sized enterprise, a national high-tech enterprise, and a Zhongguancun high-tech enterprise. The company continues to deepen its efforts in soft tissue regeneration, bone tissue regeneration, wound management, daily oral care, and comprehensive root canal treatment. It has an independent R&D team and multiple core patented technologies, establishing a relatively comprehensive service network nationwide.

Sino-Dental® (China International Dental Equipment, Materials & Technology Exhibition) is a highly authoritative and influential dental professional event in the Asia-Pacific region, with a history spanning 30 years. The exhibition is co-hosted by the International Exchange and Cooperation Center, National Health Commission of the P. R. China and the Chinese Stomatological Association (CSA), with support from Peking University School of Stomatology. Held annually in June at the Beijing National Convention Center, it serves as a core window for domestic and international industry players to observe the trends of the Chinese dental market.